Navigation Links
Lumidigm Signs Strategic Agreement with Methode Electronics : Automotive Supplier Invests in Biometric Component Development
Date:8/6/2008

Lumidigm, Inc., the biometrics company enabling applications for the real world, has formalized a strategic business alliance with Methode Electronics, Inc. One of the many businesses that make up Methode includes being a solid Tier 1 automotive supplier focusing on technology-rich application-specific components and subsystem devices. Together, Methode and Lumidigm will bring patented biometric functionality to new markets, including transportation. The partnership includes equity financing and multiple joint development projects. Methode joins current Lumidigm strategic investors Intel Capital and Motorola Ventures.

ALBUQUERQUE, N.M. (Business Wire EON) August 6, 2008 -- "Lumidigm's technology and products have always attracted companies on the cutting edge of consumer product development," said Bob Harbour, Lumidigm President and CEO. "Methode understands the unique value of Lumidigm's biometric technology and how it can enhance the automotive customer's individual experience."

Lumidigm biometric sensors enable convenient, secure, and reliable identification and verification through the use of patented multispectral imaging technology. Already used worldwide in various identification management and security applications, Lumidigm sensors are now extending biometrics to consumer applications, such as convenience and security in the automobile.

It is this commercial potential that caught the attention of Donald W. Duda, President and Chief Executive Officer of Methode Electronics, Inc. "We believe Lumidigm's biometric sensors could be used to support potential vehicle features such as keyless entry, ignition authorization, authentication of in-vehicle transactions via telematics, as well as personalization of a vehicle's convenience characteristics," said Duda. "We've entered into this strategic business alliance with Lumidigm to pu
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Lumidigm Signs Strategic Agreement with Methode Electronics :  Automotive Supplier Invests in Biometric Component Development 
(Date:5/19/2013)... 2013 The JM Internet Group (web: ... has proudly announced that the company's YouTube channel on ... 175,000 views on YouTube. The company uses YouTube as ... tips and training for small businesses with much success. ... YouTube tips helpful for their SEO strategies", explained Jason ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Dr. Sparano ... and Women’s Health at the Albert Einstein College of ... at the Montefiore Medical Center. He is also ... Center and leads the Einstein Breast Cancer Working Group, ... translational breast cancer research. He also serves as Vice ...
(Date:5/17/2013)... transplant recipient,s immune system identifies the transplanted organ as ... that T cells, the immune cells that mediate rejection, ... in order to migrate to the transplanted organ. In ... , Fadi Lakkis and colleagues at the University of ... T cells is not required for migration. Instead, these ...
(Date:5/17/2013)... 17, 2013 - Elsevier, a world-leading provider of scientific, ... the publication of a recent study in ... blastocysts showing that those with an abnormal chromosomal composition ... have developed to blastocysts, thereby classifying the risk of ... the same group has undertaken a retrospective study, using ...
Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3
... and the public agree that the promise of nanotechnology is ... be governed accordingly. , The new technology, which is ... to computers, is seen differently among scientists than the general ... areas. But in broad categories of risk versus reward both ...
... N.Y., Feb. 15 EUSA Pharma (Oxford, UK), ... licensed OP-R003,a human anti-interleukin-6 antibody discovered by Vaccinex, ... product license, GSK will pay an up-front,license fee, ... the exclusive world-wide rights to develop and commercialize,OP-R003 ...
... Data presented at the 2008 Genitourinary Cancers ... OncoGenex Technologies Inc. announced,today that the Company,s ... as custirsen, was well-tolerated in combination with ... in patients with,hormone refractory prostate cancer. Additionally, ...
Cached Biology Technology:Nanotech's health, environmental impacts worry scientists and the public 2Nanotech's health, environmental impacts worry scientists and the public 3Vaccinex Antibody Licensed to GlaxoSmithKline 2OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 2OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 3OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 4
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) explores ... and lifestyle. , Individuals suffering from Crohn,s ... fatigue and poor quality of life. These symptoms ... A randomized, double blind, placebo-controlled study found for ... to significant relief of these symptoms. , ...
(Date:5/17/2013)... Atlanta residents of all ages will celebrate the ... impact on our daily lives during the inaugural ... engineers and educators from local museums, corporations, K-12 ... than 40 different events for children and adults ... http://atlantasciencefestival.org . , The annual Atlanta ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3First Atlanta Science Festival set for 2014 2
... may emerge from a laboratory model that has just been ... human immune stem cells from umbilical cord blood into mice ... live alongside the mouse,s own immune system. Although mice ... causes typhoid fever, the bacteria are able to reproduce in ...
... Md. (September 22, 2010) The National Science Foundation ... Science Chesapeake Biological Laboratory $1.7 million to repair and ... Since 1936, the pier has played an instrumental role ... on climate change, fisheries management and the health of ...
... The antibacterial ingredient in some soaps, toothpastes, odor-fighting socks, ... long-sought new treatment for a parasitic disease that affects ... became the guiding light for future development of drugs ... Medicinal Chemistry . In the study, Rima McLeod ...
Cached Biology News:Humanized mice may provide clues to better prevent and treat typhoid fever 2Humanized mice may provide clues to better prevent and treat typhoid fever 3UMCES Chesapeake Biological Laboratory to rebuild historic research pier 2
Complete cell culture media with cytokines...
Request Info...
Contains 0.2 g/L EDTA4Na in phosphate-buffered saline....
... X-Gal ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C ... Cl N O 6 ,M.W.= ... ,Solution: Clear (2% in DMF) ,Biological ... and M13 ,Elemental Analysis: Agrees with ...
Biology Products: